Erlotinib is effective for advanced non-small cell lung cancer
Erlotinib is effective for advanced non-small cell lung cancer September 4, 2018 Source: Health News Recently, the American Medical Association's association magazine "American Medical Association Journal on Oncology" published a large-scale, multi-center, forward-looking three-phase project led by Professor Han Baohui, director of the Department of Respiratory Medicine, Shanghai Chest Hospital, and a total of 42 centers across the country. Clinical findings: The use of iropinib in patients with non-small cell lung cancer for third-line and third-line therapy can benefit significantly. This brings hope to the treatment of patients with advanced lung cancer. At present, the lack of standard and effective programs for third-line treatment of advanced non-small cell lung cancer makes the treatment of this part of the patient controversial. The penolidine hydrochloride capsule is a domestically produced 1.1 class of innovative drugs, which can strongly inhibit multiple targets, and has the dual functions of anti-tumor angiogenesis and tumor growth inhibition. The study enrolled 439 patients from 42 centers across the country. The results showed that erlotinib reduced the risk of disease progression and death by 75% and 32%, respectively, confirming that the use of erlotinib in patients with non-small cell lung cancer for third-line and third-line therapy can significantly benefit. Erlotinib has become the first multi-targeted drug for successful treatment of lung cancer in the field of lung cancer. It has established a standard for third-line treatment of advanced non-small cell lung cancer, which has changed the treatment status of advanced non-small cell lung cancer in China. It is reported that the mid-term results of the study have been invited to make oral presentations at the World Lung Cancer Congress, and the full results of the study were published at the annual meeting of the American Society of Clinical Oncology, which has aroused widespread concern in the industry. In 2017, Erlotinib was included in the green approval channel of the State Food and Drug Administration for the dual reasons of “significant advantages compared with existing treatment methods†and “significant special itemsâ€, and was listed in May 2018 for use in late non-period. Third-line treatment for patients with small cell lung cancer. (Special correspondent Yang Jing)
Perforated Metal
The perforated metal including glavanized perforated metal, stainless steel perforated metal, painted perforated metal, aluminium perforated metal, etc .
Hole type: round, long circle, oval, square, rectangular, diamond, hexagon, cross-shaped and other special-shaped hole
The technology of perforated metal : stamping, leveling, cutting, bending, reel, welding, stereotypes, surface treatment.
In
generally , the perforated metal be used on mining, machinery,
food,sports supplies, kitchen supplies, silencer, decorative,
construction, electronics and transportation .
Perforated Metal,Perforated Aluminium Mesh,Perforated Metal Screen,Wire Mesh Tray ANPING COUNTY SHANGCHEN WIREMESH PRODUCTS CO.,LTD , https://www.scwiremesh.com
